Digoxin-verapamil interaction
- 31 August 1981
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacology & Therapeutics
- Vol. 30 (3) , 311-316
- https://doi.org/10.1038/clpt.1981.165
Abstract
To explore a possible interaction between digoxin and verapamil, a single-dose kinetic study of digoxin was performed and then repeated after 10 days of verapamil treatment in 8 healthy subjects. Verapamil diminished the apparent central distribution volume of digoxin from 0.83 .+-. 0.25 to 0.64 .+-. 0.17 l/kg (P < 0.05) and reduced total body clearance of digoxin from 3.28 .+-. 0.58 to 2.15 .+-. 0.66 ml/min per kg (P < 0.001) by impairing both renal and extrarenal clearance. Biological digoxin half-life rose from 38.6 .+-. 8.5 to 50.5 .+-. 8.3 h (P < 0.005). Reduction of renal clearance of digoxin may be due to inhibition of tubular secretion. The underlying mechanisms of extrarenal interaction are not known, but impaired hepatic degradation of digoxin induced by verapamil should be considered.This publication has 7 references indexed in Scilit:
- Reduction of digoxin-induced inotropism during quinidine administrationClinical Pharmacology & Therapeutics, 1980
- The Effect of Quinidine on Digoxin Kinetics in Cardiac PatientsActa Medica Scandinavica, 1980
- Digoxin-Quinidine InteractionNew England Journal of Medicine, 1979
- Dose-independent pharmacokinetics of digoxin in humansAmerican Heart Journal, 1978
- Digoxin metabolism in patientsArchives of internal medicine (1960), 1978
- Quinidine SyncopeCirculation, 1964
- IPROVERATRIL - EXPERIMENTAL DATA ON CORONARY DILATATION + ANTIARRHYTHMIC ACTION1964